Allscripts Healthcare Solutions Stock Forecast, Price & News

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

Is Allscripts Healthcare Solutions a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Allscripts Healthcare Solutions stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View analyst ratings for Allscripts Healthcare Solutions or view top-rated stocks.

What stocks does MarketBeat like better than Allscripts Healthcare Solutions?

Wall Street analysts have given Allscripts Healthcare Solutions a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Allscripts Healthcare Solutions wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Allscripts Healthcare Solutions.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) announced its quarterly earnings data on Wednesday, August, 4th. The software maker reported $0.23 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.17 by $0.06. The software maker earned $373.70 million during the quarter, compared to the consensus estimate of $372.51 million. Allscripts Healthcare Solutions had a net margin of 49.61% and a trailing twelve-month return on equity of 7.06%.
View Allscripts Healthcare Solutions' earnings history.

How has Allscripts Healthcare Solutions' stock price been impacted by Coronavirus?

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MDRX stock has increased by 117.1% and is now trading at $13.70.
View which stocks have been most impacted by COVID-19.

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions announced that its board has initiated a stock buyback program on Wednesday, May 26th 2021, which permits the company to buyback $350,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 14% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.50 billion-$1.50 billion, compared to the consensus revenue estimate of $1.50 billion.

What price target have analysts set for MDRX?

10 analysts have issued 1 year price objectives for Allscripts Healthcare Solutions' shares. Their forecasts range from $11.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $15.75 in the next year. This suggests a possible upside of 15.0% from the stock's current price.
View analysts' price targets for Allscripts Healthcare Solutions or view top-rated stocks among Wall Street analysts.

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the following people:

• Paul M. Black, Chief Executive Officer & Director
• Richard J. Poulton, President & Chief Financial Officer
• Joseph R. Rostock, Chief Technology Officer & Senior VP-Development
• Lisa Khorey, Chief Client Delivery Officer & Executive VP
• Eric Jacobson, Secretary & Senior Vice President

What is Paul Black's approval rating as Allscripts Healthcare Solutions' CEO?

796 employees have rated Allscripts Healthcare Solutions CEO Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among Allscripts Healthcare Solutions' employees.

Who are some of Allscripts Healthcare Solutions' key competitors?

Some companies that are related to Allscripts Healthcare Solutions include Cerner (CERN), Omnicell (OMCL), Cortexyme (CRTX), Vocera Communications (VCRA), HealthStream (HSTM), Computer Programs and Systems (CPSI), Athena Technology Acquisition (ATHN) and Mirage Energy (MRGE).
View all of MDRX's competitors.

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Jefferies Group LLC (0.00%), BlackRock Inc. (17.37%), Vanguard Group Inc. (11.99%), Dimensional Fund Advisors LP (8.81%), Fisher Asset Management LLC (4.03%) and Fuller & Thaler Asset Management Inc. (4.02%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black and Richard J Poulton.
View institutional ownership trends for Allscripts Healthcare Solutions.

Which institutional investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Tamarack Advisers LP, BNP Paribas Arbitrage SA, Nuveen Asset Management LLC, Deutsche Bank AG, Fisher Asset Management LLC, Renaissance Technologies LLC, and William Blair Investment Management LLC. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, and Paul Black.
View insider buying and selling activity for Allscripts Healthcare Solutions or view top insider-selling stocks.

Which institutional investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was acquired by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Goldman Sachs Group Inc., JPMorgan Chase & Co., SG Americas Securities LLC, Invesco Ltd., Jefferies Group LLC, First Trust Advisors LP, and WINTON GROUP Ltd. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Paul Black, and Richard J Poulton.
View insider buying and selling activity for Allscripts Healthcare Solutions or or view top insider-buying stocks.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $13.70.

How much money does Allscripts Healthcare Solutions make?

Allscripts Healthcare Solutions has a market capitalization of $1.71 billion and generates $1.50 billion in revenue each year. The software maker earns $700.41 million in net income (profit) each year or $0.56 on an earnings per share basis.

How many employees does Allscripts Healthcare Solutions have?

Allscripts Healthcare Solutions employs 8,400 workers across the globe.

Does Allscripts Healthcare Solutions have any subsidiaries?

The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.

When was Allscripts Healthcare Solutions founded?

Allscripts Healthcare Solutions was founded in 1986.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

Where are Allscripts Healthcare Solutions' headquarters?

Allscripts Healthcare Solutions is headquartered at 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at (800) 334-8534 or via email at [email protected].